Ogonowski J
Kliniki Endokrynologii, Nadciśnienia, Tetniczego i Chorób Przemiany Materii, Pomorskiej Akademii Medycznej w Szczecinie.
Przegl Lek. 1996;53(9):666-7.
Glipizide is a second generation of sulphonylurea compound, effective in lowering of blood glucose, well-tolerated as well as safe during long-term treatment. Glipizide is the agent characterized by rapid pharmacological action. It is indicated both in monotherapy and combined treatment with insulin or biguanides. This drug is particularly indicated in diabetes treatment in elderly patients due to short time of action as well as lack of hyperinsulinemic effect. Data in literature suggest that glipizide combined with insulin is much more effective in the induction of remission in recent diagnosed diabetes when compared to intensive insulin therapy.
格列吡嗪是第二代磺酰脲类化合物,能有效降低血糖,耐受性良好,长期治疗安全。格列吡嗪具有药理作用迅速的特点。可用于单药治疗,也可与胰岛素或双胍类联合治疗。由于作用时间短且无高胰岛素血症效应,该药物特别适用于老年患者的糖尿病治疗。文献数据表明,与强化胰岛素治疗相比,格列吡嗪联合胰岛素在诱导新诊断糖尿病缓解方面更有效。